DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,122,660 | -4.6% | 109,321 | -7.7% | 1.99% | +5.6% |
| Q2 2023 | $28,436,481 | -2.8% | 118,485 | +2.0% | 1.88% | -5.5% |
| Q1 2023 | $29,268,444 | -5.3% | 116,126 | -0.2% | 1.99% | -11.2% |
| Q4 2022 | $30,899,151 | -9.4% | 116,416 | -11.8% | 2.24% | -12.3% |
| Q3 2022 | $34,110,000 | +1.2% | 132,061 | -0.6% | 2.56% | +1.4% |
| Q2 2022 | $33,693,000 | -14.6% | 132,899 | -1.2% | 2.52% | +16.3% |
| Q1 2022 | $39,471,000 | -26.6% | 134,559 | -17.7% | 2.17% | -19.3% |
| Q4 2021 | $53,774,000 | +5.9% | 163,443 | -2.0% | 2.69% | -3.0% |
| Q3 2021 | $50,777,000 | +13.1% | 166,788 | -0.3% | 2.77% | +20.1% |
| Q2 2021 | $44,886,000 | +18.4% | 167,260 | -0.7% | 2.31% | +11.7% |
| Q1 2021 | $37,919,000 | -5.9% | 168,468 | -7.1% | 2.07% | -14.0% |
| Q4 2020 | $40,301,000 | -9.7% | 181,418 | -12.5% | 2.40% | -20.2% |
| Q3 2020 | $44,648,000 | +18.8% | 207,347 | -2.4% | 3.01% | +10.7% |
| Q2 2020 | $37,567,000 | +13.7% | 212,444 | -11.0% | 2.72% | +1.5% |
| Q1 2020 | $33,053,000 | -13.7% | 238,801 | -4.3% | 2.68% | +1.3% |
| Q4 2019 | $38,306,000 | +3.7% | 249,587 | -2.4% | 2.65% | -1.6% |
| Q3 2019 | $36,923,000 | -0.6% | 255,646 | -1.6% | 2.69% | +2.6% |
| Q2 2019 | $37,142,000 | -2.2% | 259,880 | -9.7% | 2.62% | +10.4% |
| Q1 2019 | $37,975,000 | +25.8% | 287,641 | -1.7% | 2.38% | +2.3% |
| Q4 2018 | $30,182,000 | -9.7% | 292,691 | -4.9% | 2.32% | +8.8% |
| Q3 2018 | $33,429,000 | +3.8% | 307,651 | -5.7% | 2.14% | +2.5% |
| Q2 2018 | $32,201,000 | +0.4% | 326,311 | -0.4% | 2.08% | -8.7% |
| Q1 2018 | $32,066,000 | +1.3% | 327,501 | -3.9% | 2.28% | +1.6% |
| Q4 2017 | $31,640,000 | +8.7% | 340,881 | +0.5% | 2.24% | +2.8% |
| Q3 2017 | $29,109,000 | +16.5% | 339,350 | +14.7% | 2.18% | +14.8% |
| Q2 2017 | $24,977,000 | – | 295,965 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |